Keywords: epo, revokes, osi, dpp-4, patent, pharmaceuticals, says

EPO revokes an OSI DPP-4 patent

Article | 21 April 2008

Print This

OSI Pharmaceuticals says that the European Patent Office has revoked one of its dipeptidyl peptidase-4 patents, EP0896538, claiming the use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in